F Dx Advisors, Inc. Bio Rad Laboratories, Inc. Transaction History

F Dx Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$269.37 - $365.04 $41,752 - $56,581	155 Added 25.92%	753 $243,000
Q3 2023 Nov 02, 2023	BUY	$350.25 - $422.63 $209,449 - $252,732	598 New	598 $214,000
Q3 2020 Nov 12, 2020	SELL	$454.43 - $535.6 $335,369 - $395,272	-738 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$334.87 - $493.06 $7.09 Million - $10.4 Million	-21,176 Reduced 96.63%	738 $333,000
Q1 2020 May 13, 2020	BUY	$320.01 - $409.07 $7.01 Million - $8.96 Million	21,914 New	21,914 $677,000
Q4 2017 Feb 09, 2018	SELL	$216.94 - $271.3 $397,434 - $497,021	-1,832 Closed	0 $0
Q3 2017 Nov 03, 2017	SELL	$212.27 - $242.28 $168,542 - $192,370	-794 Reduced 30.24%	1,832 $407,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,626	2,626 $594,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.38B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.